Vilket är priset för Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762)

Priset för Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762) är $1.15

Vilket är marknadsvärdet för Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762)

Marknadsvärdet för Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762) är $88.79M

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762) Vinst per Aktie

Based in New Taipei City, Taiwan, Chunghwa Chemical Synthesis & Biotech Co., Ltd., established in 1964 and previously known as China Chemical Synthesis Industry Co., Ltd., specializes in the development, production, and distribution of active pharmaceutical ingredients (APIs). The company's market reach includes Taiwan and the United States. Their API portfolio encompasses products designed for immunosuppression, oncology, and cardiovascular conditions, in addition to various peptide compounds. Moreover, they manufacture a wide array of bulk pharmaceutical substances for numerous therapeutic applications, including anti-anxiety agents, antidiabetics, laxatives, antifungals, antihistamines, antiseptics, antiulcerants, cardiovascular medications, skeletal muscle relaxants, hypolipidemics, antineoplastics, antihyperlipidemics, and immunosuppressants. Complementing its product offerings, Chunghwa Chemical Synthesis & Biotech delivers bespoke research and development as well as contract manufacturing services to both emerging drug developers and established generic pharmaceutical firms.

År	EPS	Ändra
Inte tillräckligt med data för de angivna datumen.

År

EPS

Ändra

Inte tillräckligt med data för de angivna datumen.

Företag	EPS	EPS-differens	Land
Royalty Pharma plc RPRX.US	$2.41	-	US
Swedish Orphan Biovitrum AB SOBI.ST	-	-	SE
Ipsen S.A. IPN.PA	-	-	FR
Corcept Therapeutics Incorporated CORT.US	$0.52	-	US
Recordati Industria Chimica e Farmaceutica S.p.A. REC.MI	-	-	IT

Företag

EPS

EPS-differens

Land